$HEMISPHERX BIOPHARMA INC(HEB)$ UPDATE -- Hemispherx Amends and Restates Agreement with myTomorrows for the Early Access Program for Rintatolimod in Europe.
网页链接
雪球转发:0回复:0喜欢:0